These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 18668375

  • 1. Prescribing and monitoring clozapine in Christchurch.
    McKean A, Vella-Brincat J, Begg E.
    Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Importance of determining clozapine plasma level in follow-up of schizophrenic patients].
    Vailleau JL, Jeanny B, Chomard P, Vincent R.
    Encephale; 1996 Aug; 22(2):103-9. PubMed ID: 8706619
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P, Bret MC, Queuille E.
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [Abstract] [Full Text] [Related]

  • 9. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
    Müller MJ, Eich FX, Regenbogen B, Sachse J, Härtter S, Hiemke C.
    J Psychopharmacol; 2009 May; 23(3):278-86. PubMed ID: 18562411
    [Abstract] [Full Text] [Related]

  • 10. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
    Freudenreich O, Weiner RD, McEvoy JP.
    Biol Psychiatry; 1997 Jul 15; 42(2):132-7. PubMed ID: 9209730
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clozapine in the treatment of mental manifestations of Parkinson disease].
    Diederich N, Keipes M, Graas M, Metz H.
    Rev Neurol (Paris); 1995 Apr 15; 151(4):251-7. PubMed ID: 7481376
    [Abstract] [Full Text] [Related]

  • 15. Clozapine use in a forensic population in a New South Wales prison hospital.
    Martin A, O'Driscoll C, Samuels A.
    Aust N Z J Psychiatry; 2008 Feb 15; 42(2):141-6. PubMed ID: 18197509
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
    Müller MJ, Regenbogen B, Härtter S, Eich FX, Hiemke C.
    J Psychiatr Res; 2007 Oct 15; 41(8):673-9. PubMed ID: 16324716
    [Abstract] [Full Text] [Related]

  • 17. Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context.
    Malhi G, Adams D, Plain J, Coulston C, Herman M, Walter G.
    Australas Psychiatry; 2010 Feb 15; 18(1):32-41. PubMed ID: 20039791
    [Abstract] [Full Text] [Related]

  • 18. [Blood clozapine level and therapeutic adjustment].
    Préterre P.
    Encephale; 1995 Jun 15; 21 Spec No 3():53-7. PubMed ID: 7628343
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The use of clozapine in adults with intellectual disability.
    Thalayasingam S, Alexander RT, Singh I.
    J Intellect Disabil Res; 2004 Sep 15; 48(Pt 6):572-9. PubMed ID: 15312058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.